Literature DB >> 20194487

Assuring that double-blind is blind.

Roy H Perlis, Michael Ostacher, Maurizio Fava, Andrew A Nierenberg, Gary S Sachs, Jerrold F Rosenbaum.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 20194487     DOI： 10.1176/appi.ajp.2009.09060820

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  16 in total

1.  The role of regulators, investigators, and patient participants in the rise of the placebo response in major depressive disorder.

Authors:  Maurizio Fava
Journal:  World Psychiatry       Date:  2015-10       Impact factor: 49.548

2.  Improving function in age-related macular degeneration: design and methods of a randomized clinical trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Robert W Massof; Benjamin E Leiby; William S Tasman
Journal:  Contemp Clin Trials       Date:  2010-10-23       Impact factor: 2.226

3.  Improving study design for antidepressant effectiveness assessment.

Authors:  Florian Naudet; Bruno Millet; Jean Michel Reymann; Bruno Falissard
Journal:  Int J Methods Psychiatr Res       Date:  2013-08-30       Impact factor: 4.035

4.  Amygdala abnormalities in first-degree relatives of individuals with schizophrenia unmasked by benzodiazepine challenge.

Authors:  Daniel H Wolf; Theodore D Satterthwaite; James Loughead; Amy Pinkham; Eve Overton; Mark A Elliott; Gersham W Dent; Mark A Smith; Ruben C Gur; Raquel E Gur
Journal:  Psychopharmacology (Berl)       Date:  2011-05-21       Impact factor: 4.530

5.  Impact of midazolam vs. saline on effect size estimates in controlled trials of ketamine as a rapid-acting antidepressant.

Authors:  Samuel T Wilkinson; Cristan Farmer; Elizabeth D Ballard; Sanjay J Mathew; Michael F Grunebaum; James W Murrough; Peter Sos; Gang Wang; Ralitza Gueorguieva; Carlos A Zarate
Journal:  Neuropsychopharmacology       Date:  2019-01-17       Impact factor: 7.853

6.  Ketamine induced changes in regional cerebral blood flow, interregional connectivity patterns, and glutamate metabolism.

Authors:  James Edward Bryant; Michael Frölich; Steve Tran; Meredith Amanda Reid; Adrienne Carol Lahti; Nina Vanessa Kraguljac
Journal:  J Psychiatr Res       Date:  2019-07-27       Impact factor: 4.791

Review 7.  Comparative Effectiveness and Safety of Cognitive Behavioral Therapy and Pharmacotherapy for Childhood Anxiety Disorders: A Systematic Review and Meta-analysis.

Authors:  Zhen Wang; Stephen P H Whiteside; Leslie Sim; Wigdan Farah; Allison S Morrow; Mouaz Alsawas; Patricia Barrionuevo; Mouaffaa Tello; Noor Asi; Bradley Beuschel; Lubna Daraz; Jehad Almasri; Feras Zaiem; Laura Larrea-Mantilla; Oscar J Ponce; Annie LeBlanc; Larry J Prokop; Mohammad Hassan Murad
Journal:  JAMA Pediatr       Date:  2017-11-01       Impact factor: 16.193

8.  Not All Masks Are Created Equal: Masking Success in Clinical Trials of Children and Adolescents.

Authors:  Lauren Jones; Sarah R Black; L Eugene Arnold; Mary A Fristad
Journal:  J Clin Child Adolesc Psychol       Date:  2017-07-17

9.  Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes.

Authors:  Glen I Spielmans; Margit I Berman; Eftihia Linardatos; Nicholas Z Rosenlicht; Angela Perry; Alexander C Tsai
Journal:  PLoS Med       Date:  2013-03-12       Impact factor: 11.069

10.  Antidepressant response in major depressive disorder: a meta-regression comparison of randomized controlled trials and observational studies.

Authors:  Florian Naudet; Anne Solène Maria; Bruno Falissard
Journal:  PLoS One       Date:  2011-06-08       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.